Compare COEP & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COEP | CLPR |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 67.0M |
| IPO Year | N/A | 2017 |
| Metric | COEP | CLPR |
|---|---|---|
| Price | $15.85 | $3.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 71.0K | 56.9K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 10.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $500,996.00 | ★ $154,179,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.90 |
| 52 Week Low | $2.31 | $3.37 |
| 52 Week High | $21.41 | $6.49 |
| Indicator | COEP | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 31.59 |
| Support Level | $15.40 | $3.57 |
| Resistance Level | $16.80 | $3.65 |
| Average True Range (ATR) | 1.57 | 0.15 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 20.64 | 2.05 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.